PSYCH up2date, Table of Contents PSYCH up2date 2018; 12(02): 139-150DOI: 10.1055/s-0043-110841 Persönlichkeitsstörungen, Impulskontrollstörungen und dissoziative Störungen Borderline-Persönlichkeitsstörung Anja Schaich , Nele Erkens , Ulrich Schweiger , Eva Faßbinder Recommend Article Abstract Buy Article All articles of this category Die Borderline-Persönlichkeitsstörung (BPS) ist eine ernste, aber behandelbare psychische Erkrankung. Psychotherapie ist Behandlung der Wahl, eine psychopharmakologische Behandlung der BPS ist nicht evidenzbasiert. Die Schulung medizinischen Personals in Diagnostik und Behandlung von Patienten mit BPS ist dringend notwendig, um Stigmatisierung zu reduzieren und eine adäquate ambulante Versorgung dieser Patientengruppe zu gewährleisten. Schlüsselwörter SchlüsselwörterDiagnosekriterien - Störungsbild - Symptomatik - Komorbidität - Psychotherapie Full Text References Literatur 1 American Psychiatric Association. Diagnostic and statistical Manual of mental Disorders (DSM-5®). Washington, DC: American Psychiatric Pub; 2013 2 World Health Organization. The ICD-10 Classification of mental and behavioural Disorders: clinical Descriptions and diagnostic Guidelines. Genf: World Health Organization; 1992 3 Wittchen HU, Zaudig M, Fydrich T. SKID. Strukturiertes klinisches Interview für DSM-IV. Achse I und II. Handanweisung. Göttingen: Hogrefe; 1997 4 Gunderson JG, Stout RL, Shea MT. et al. Interactions of borderline personality disorder and mood disorders over ten years. J Clin Psychiatry 2014; 75: 829 5 Bach B, Sellbom M, Skjernov M. et al. ICD-11 and DSM-5 personality trait domains capture categorical personality disorders: Finding a common ground. Aust N Z J Psychiatry 2017; 6 Tomko RL, Trull TJ, Wood PK. et al. Characteristics of borderline personality disorder in a community sample: comorbidity, treatment utilization, and general functioning. J Pers Disord 2014; 28: 734-750 7 ten Have M, Verheul R, Kaasenbrood A. et al. Prevalence rates of borderline personality disorder symptoms: a study based on the Netherlands Mental Health Survey and Incidence Study-2. BMC Psychiatry 2016; 16: 249 8 Wagner T, Fydrich T, Stiglmayr C. et al. Societal cost-of-illness in patients with borderline personality disorder one year before, during and after dialectical behavior therapy in routine outpatient care. Behav Res Ther 2014; 61: 12-22 9 Zanarini MC, Frankenburg FR, Dubo ED. et al. Axis I comorbidity of borderline personality disorder. Am J Psychiatry 1998; 155: 1733-1739 10 Zanarini MC, Frankenburg FR, Dubo ED. et al. Axis II comorbidity of borderline personality disorder. Compr Psychiatry 1998; 39: 296-302 11 McGlashan TH, Grilo CM, Skodol AE. et al. The Collaborative Longitudinal Personality Disorders Study: baseline Axis I/II and II/II diagnostic co-occurrence. Acta Psychiatrica Scand 2000; 102: 256-264 12 Barrachina J, Pascual JC, Ferrer M. et al. Axis II comorbidity in borderline personality disorder is influenced by sex, age, and clinical severity. Compr Psychiatry 2011; 52: 725-730 13 Silberschmidt A, Lee S, Zanarini M. et al. Gender differences in borderline personality disorder: results from a multinational, clinical trial sample. J Pers Disord 2015; 29: 828-838 14 Fok ML, Hayes RD, Chang CK. et al. Life expectancy at birth and all-cause mortality among people with personality disorder. J Psychosom Res 2012; 73: 104-107 15 Kahl KG, Greggersen W, Schweiger U. et al. Prevalence of the metabolic syndrome in patients with borderline personality disorder: results from a cross-sectional study. Eur Arch Psychiatry Clin Neurosci 2013; 263: 205-213 16 El-Gabalawy R, Katz LY, Sareen J. Comorbidity and associated severity of borderline personality disorder and physical health conditions in a nationally representative sample. Psychosom Med 2010; 72: 641-647 17 Frankenburg FR, Zanarini MC. The association between borderline personality disorder and chronic medical illnesses, poor health-related lifestyle choices, and costly forms of health care utilization. J Clin Psychiatry 2004; 65: 1660-1665 18 Lam DC, Salkovskis PM, Hogg LI. ‘Judging a book by its cover’: An experimental study of the negative impact of a diagnosis of borderline personality disorder on cliniciansʼ judgements of uncomplicated panic disorder. Br J Clin Psychol 2016; 55: 253-268 19 Strauß B. Chancenungleichheit auf der Suche nach einem Therapieplatz. Psychotherapeut 2015; 60: 389-396 20 Jobst A, Hörz S, Birkhofer A. et al. Einstellung von Psychotherapeuten gegenüber der Behandlung von Patienten mit Borderline Persönlichkeitsstörung. PPmP-Psychother Psychosom Med Psychol 2010; 60: 126-131 21 Keuroghlian AS, Palmer BA, Choi-Kain LW. et al. The effect of attending good psychiatric management (GPM) workshops on attitudes toward patients with borderline personality disorder. J Pers Disord 2016; 30: 567-576 22 Knaak S, Szeto ACh, Fitch K. et al. Stigma towards borderline personality disorder: effectiveness and generalizability of an anti-stigma program for healthcare providers using a pre-post randomized design. Borderline Personal Disord Emot Dysregul 2015; 2: 9 23 Sharp C, Fonagy P. Practitioner Review: Borderline personality disorder in adolescence–recent conceptualization, intervention, and implications for clinical practice. J Child Psychol Psychiatry 2015; 56: 1266-1288 24 Griffiths M. Validity, utility, and acceptability of borderline personality disorder diagnosis in childhood and adolescence: survey of psychiatrists. The Psychiatrist 2011; 35: 19-22 25 Zanarini MC, Horwood J, Wolke D. et al. Prevalence of DSM-IV borderline personality disorder in two community samples: 6,330 English 11-year-olds and 34,653 American adults. J Pers Disord 2011; 25: 607-619 26 Zanarini MC, Temes CM, Magni LR. et al. Prevalence rates of borderline symptoms reported by adolescent inpatients with BPD, psychiatrically healthy adolescents and adult inpatients with BPD. Personal Ment Health 2017; 11: 150-156 27 Merza K, Papp G, Kuritárné Szabó I. The role of childhood traumatization in the development of borderline personality disorder in Hungary. Eur J Psychiatry 2015; 29: 105-118 28 Gunderson JG, Zanarini MC, Choi-Kain LW. et al. Family study of borderline personality disorder and its sectors of psychopathology. Arch Gen Psychiatry 2011; 68: 753-762 29 Amad A, Ramoz N, Thomas P. et al. Genetics of borderline personality disorder: systematic review and proposal of an integrative model. Neurosci Biobehav Rev 2014; 40: 6-19 30 Witt SH, Streit F, Jungkunz M. et al. Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia. Transl Psychiatry 2017; 7: e1155 31 Fiedler P, Herpertz S. Persönlichkeitsstörungen. Weinheim: Beltz Verlag; 2016 32 Zanarini MC, Frankenburg FR, Reich DB. et al. Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and axis II comparison subjects: a 16-year prospective follow-up study. Am J Psychiatry 2012; 169: 476-483 33 Zanarini MC, Frankenburg FR, Reich DB. et al. Fluidity of the subsyndromal phenomenology of borderline personality disorder over 16 years of prospective follow-up. Am J Psychiatry 2016; 173: 688-694 34 Choi-Kain LW, Finch EF, Masland SR. et al. What works in the treatment of borderline personality disorder. Curr Behav Neurosci Reports 2017; 4: 21-30 35 Cristea IA, Gentili C, Cotet CD. et al. Efficacy of psychotherapies for borderline personality disorder: A systematic review and meta-analysis. JAMA Psychiatry 2017; 74: 319-328 36 Bateman AW, Fonagy P. Handbuch Mentalisieren. Gießen: Psychosozial-Verlag; 2014 37 Clarkin JF, Yeomans FE, Kernberg OF. Psychotherapie der Borderline-Persönlichkeit. Stuttgart: Schattauer; 2008 38 Bohus M, Wolf-Arehult M. Interaktives Skillstraining für Borderline-Patienten. Stuttgart: Schattauer; 2012 39 Linehan M. DBT. Handbuch beide Bände. München: CIP-Medien; 2016 40 Arntz A, van Genderen H, Schweiger U. Schematherapie bei Borderline-Persönlichkeitsstörung. Weinheim: Beltz; 2010 41 Stoffers J, Völlm BA, Rücker G. et al. Pharmacological interventions for borderline personality disorder. Cochrane Database Syst Rev 2010; (06) CD005653 42 Lieb K, Völlm B, Rücker G. et al. Pharmacotherapy for borderline personality disorder. Br J Psychiatry 2010; 196: 4-12 43 Chanen AM, Thompson KN. Prescribing and borderline personality disorder. Australian Prescriber 2016; 39: 49 44 Rief W, Barsky A, Bingel U. et al. Rethinking psychopharmacotherapy: the role of treatment context and brain plasticity in antidepressant and antipsychotic interventions. Neurosci Biobehavl Rev 2016; 60: 51-64 45 Zanarini MC, Frankenburg FR, Hennen J. et al. Mental health service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 years. J Clin Psychiatry 2004; 65: 28-36
